Skip to Main Content
Table 2

Tumor regression by in vivo administration of anti-CD25 (IL-2Rα) mAb (PC61)

Tumor regression by in vivo administration of anti-CD25 (IL-2Rα) mAb (PC61)
View large
Tumor regression by in vivo administration of anti-CD25 (IL-2Rα) mAb (PC61)
View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept